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INTRODUCTION
The goal of this research is to compare the effects of three months, three times a week aquatic therapy with similar intensity robotically assisted, body weight supported aerobic treadmill training upon functional ambulatory ability, cardiovascular fitness, and metabolic changes in individuals with chronic (greater than 12 months post injury) motor incomplete spinal cord injury (MISCI). It is anticipated that 36 individuals with chronic MISCI will enroll in this study. We hypothesize that aquatic therapy will be more effective than robotically assisted aerobic locomotor training in improving functional ability as measured by timed walks, a gait mat device and community step activity monitors. Furthermore, we also hypothesize that aquatic therapy will be more effective than robotic locomotor therapy in improving cardiovascular fitness as measured by open circuit spirometry during arm ergometry in these individuals. This work will provide preliminary evidence-based information as to the efficacy of aquatic therapy and robotically assisted, body weight supported aerobic treadmill training in chronic spinal cord injury motor system rehabilitation. A need for empirical data exists, as there is little objective data examining either of these two interventions after spinal cord injury.
BODY
Statement of Work (SOW) Tasks are listed below, and are followed (in blue and bold font) with description of the actual accomplishments during this annual study period.
Task 1: Implement plans, obtain IRB study approval and start up. (Month 1-6)
1a.
Complete the formal study protocol, case report forms, data collection sheets, and informed consent documents. Ensure consistency in these documents across the two sites. (Month 1-2) 1b.
Concurrently submit the protocol and regulatory documents to the University of Maryland at Baltimore and the Shepherd Center IRBs. (Month 2-6) 1c.
Obtain research certification for all study personnel if not already obtained. Renew this certification annually or as required. 1d.
Once IRB approval has been obtained, submit the protocol and regulatory documents to the respective VA Research Committees and the Medical Executive committee at Kernan Hospital. (Month 3-6) 1e.
Develop an organizational meeting in Baltimore or Atlanta to allow for concurrent initiation and coordination of the research study (Month 5-6).
1a-e. As reported in prior quarterly reports, all of these tasks were completed in alignment with the SOW. Initiate screening of potential individuals for the research study (General medical and ASIA examination, blood tests, EKG, Standing frame challenge) (Months 7-9) 2b.
Obtain baseline measurements (VO 2 max, Timed walked tests, GAITRite,
Step activity monitor studies) on individual study participants as they pass screening. -2 - 2c.
Initiate the stratified randomization of subjects into the Lokomat versus aquatic therapy protocols with exercise occurring 3 times per week for 3 months. (Months 7 -9) 2d.
Recruit twelve individuals across both sites during year one (approximately six per site approximately equally divided between tetraplegic and paraplegic individuals . 2e
Obtain 3 month outcome measurements after participants complete their first exercise intervention (Months 10-39). 2f.
Cross over participants to the other exercise intervention after outcome measurements have been performed (Months 10-42). 2g.
Obtain 6 month outcome measurements after participants complete their second exercise interventions (Months 12-42). Five individuals at the Baltimore site where withdrawn from study participation. One enrolled participant (at the Baltimore site) was withdrawn at his fourth training Lokomat exercise session secondary to his inability to tolerate Lokomat setup. Specifically, the fourth and final session was terminated during the warm-up period after the participant reported experiencing a "burning" sensation in the left foot. This participant reported similar symptoms during the two prior Lokomat training sessions but he did not report this symptom to the research team during the set-up and acclimation sessions. The reported paresthesia was not in a classical neuroanatomic distribution. For two of the last four attempted training sessions the participant actually reported paresthesia before leaving the exercise mat and being suspended in the Lokomat harness. To diminish or prevent this problem, the research team attempted to reposition the Lokomat straps, but was unsuccessful in ameliorating the condition during Lokomat suspension. The PI ultimately terminated the subject's participation for safety reasons.
The second participant was withdrawn on his 11th Lokomat session (after he completed the entire Aquatic therapy arm of the study with no problems) when asymptomatic autonomic dysreflexia (AD) occurred. This was detected after the participant described a 'feeling of warmth' while exercising on the Lokomat. The blood pressure taken at the time was 210/100 mmHg. The subject was otherwise asymptomatic, i.e. there was no headache or diaphoresis. The blood pressure returned to normal after the subject was taken out of the Lokomat straps. Several attempts were made to modify the straps to see if this elevation in BP could be avoided.
Unfortunately it could not.
Autonomic dysreflexia is a known complication of persons with spinal cord injury at or above the T6 level, usually caused by some sensory irritation below the level of injury. We discussed this incident with the IRB at the time it occurred. Since AD is a known complication, no reportable new information (RNI) report was required. Because of the persistent elevation in BP during the Lokomat component of the protocol (i.e. silent AD), this individual was withdrawn from the study.
An unfortunate non-study activity related, lower leg fracture necessitated withdrawal of the third participant. He was casted for 6 weeks sp fracture.
An unreported skin irritation on the plantar surface of his foot facilitated the removal of the fourth research participant. This individual does not routinely examine his skin integrity, or follow up with recommended and scheduled clinical care. Once the irritation was researcher identified, the area was examined and treated until the participant no longer returned to our facility. Attempts were made to contact him via phone and mail with no success.
The fifth participant successfully completed the aquatic intervention and 30 sessions of Lokomat and was hospitalized for a non-study condition.
All of these withdrawn individuals but the fifth who was directly admitted to the hospital from home, were medically evaluated by the PI (PHG) who determined that no further intervention was necessary other than withdrawal from participation. Two withdrawn individuals are currently engaged in our wellness aquatic programs as a secondary outcome of study participation. We will continue to diligently monitor all study participants to insure safe participation in this DOD protocol. Additionally, study withdraws were reported through our established DSMB.
KEY RESEARCH ACCOMPLISHMENTS
Completed the formal study protocol, case report forms, data collection sheets, and informed consent documents Ensured consistency in these documents across the two study sites Obtained necessary IRB (University of Maryland Baltimore, Shepherd, and DOD) study approval Filed required regulatory documents Obtained research certification for all study personnel if not already current Orchestrated organizational face to face meetings in Baltimore, Atlanta, and at national professional meetings to allow for concurrent initiation and coordination of the research study -8 - Held weekly DOD research study meetings (in Baltimore) including all local team members Planned and executed monthly phone conferencing between both study sites Scheduled weekly site meetings to discuss all aspects of this DOD study and review study protocol and procedures Submitted local IRB modification to clarify exclusion criteria so that they better align with the current clinical definition of diabetes; and to offer optional participation in MRI screening at pre, mid, and post data assessment for abdominal adiposity. Two manuscripts from screening data and study execution only Nine presentations from proposal, screening data, and study execution only:
Our plan for year four of the DOD study includes:
Obtain 6 month outcome measurements after final eight participants complete their second exercise interventions Continue to provide quarterly and annual reports to the DOD and appropriate documentation to UMB IRB.
Submit our sixth DSMB report in November 2013
Continue to enter demographic and outcome data into our study database using the established common data base SCI template Analyze both screening and outcome data Draft publication(s) discussing: clinical concepts; cardiovascular; functional; and metabolic information learned from this DOD funded study Draft a final report for DOD
REPORTABLE OUTCOMES:
No reportable outcomes available to date.
CONCLUSION:
At the conclusion of year 3 of the DOD study we met all planned proposal activities: regulatory compliance, recruitment, data collection, and fiscal responsibility; and are well positioned to complete data entry and analysis as well as craft publications to disseminate these findings.
REFERENCES: NA

APPENDICES: 1) Autonomic Dysreflexia published paper 2) Arm Ergometer and Lokomat Reliability manuscript (in press)
Case report
Atypical autonomic dysreflexia during roboticassisted body weight supported treadmill training in an individual with motor incomplete spinal cord injury
Introduction
Autonomic dysreflexia (AD) occurs frequently in individuals with spinal cord injury (SCI) at level T6 or above, including both greater than 20-30 mmHg blood pressure (BP) change, and relative bradycardia (slow heart rate). 1,2 AD with elevated BP is a known risk factor for intracerebral hemorrhage, and therefore, is treated as a medical emergency. [3] [4] [5] AD can be precipitated by various afferent irritants from below the level of the injury particularly novel stimuli such as electrical stimulation and body weight supported exercise. 6 Alan et al. reported that injury-induced vasculature changes may contribute to AD occurrence via circulatory changes and the altered ability to tolerate novel sensory input.
The syndrome is commonly associated with headache and diaphoresis, but sometimes can be asymptomatic. There are reports of silent AD during voiding, 7 bowel programs, 8 sperm retrieval, 9 and possibly accupunture. 10 It is unclear what long-term impact these large systolic blood pressure (SBP) changes cause, or what mechanism(s) stimulate these SBP fluctuations.
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Upright walking-like exercise is also reported to increase BP via exaggerated spinal reflexes in individuals with SCI at T6 or above. 12 The Consortium for Spinal Cord Medicine Clinical Practice Guidelines for the acute management of AD emphasize the need to be aware of AD symptoms, while noting that AD clinical signs are not always present. 4 Currently, it is unclear exactly how robotic-improve, with a positive impact upon blood flow in the femoral and carotid arteries is reported. 13 Krassioukov and Harkema 14 reported the need to carefully assess cardiovascular responses in individuals with upper thoracic and cervical SCI while in the BWSTT harness system, finding significant increase in arterial pressure while sitting in the harness. This pressure abrogated, however, when standing without gait training. This case report details the potential relationship between robotic-assisted BWSTT and AD in an individual with C6 AIS C chronic SCI.
Case report
A 41-year-old African-American man with C6 ASIA Impairment Scale (AIS) C Impairment Scale tetraplegia secondary to a sports injury 23 years ago participated in a body weight-supported robotic treadmill training (BWSTT) and aquatic exercise research protocol. The participant enrolled in an ongoing randomized clinical trial, approved by the University of Maryland Baltimore and Department of Defense Institutional Review Boards, to evaluate the cardiovascular and mobility effects of 3 months of robotic-assisted BWSTT exercise versus 3 months of aquatic-based exercise in people with chronic (>1 year) cervical and thoracic motor incomplete SCI. Therapist-directed exercise interventions under each arm of the protocol occurred three times per week, every other day, for 40 minutes in an outpatient rehabilitation setting. This patient uses a power wheelchair for mobility and is actively employed as a computer programmer specialist. His spasticity, primarily of the lower extremities, is well managed with oral baclofen at 10 mg three times per day. He manages his bladder with external condom catheter drainage and his bowel routine includes every other day bisacodyl suppositories. His remote history includes renal stones and headache in the context of bladder distension and the passage of renal calculi. Serial imaging studies of his collecting system during the last few years, however, demonstrated no hydronephrosis or renal stones, and serial blood tests document normal renal function.
Randomized to start in the aquatic therapy intervention, J.W. completed 36 aquatic therapy sessions over 12 weeks with no known AD occurrence. Vital signs were assessed at the beginning and end of each aquatic therapy session with no significant changes noted. BP readings were also unchanged during peak VO 2 arm ergometry testing, a study outcome measure, and during his pre-study standing frame assessment.
The robotic-assisted BWSTT (Lokomat ® ) intervention consisted of the standard partial weight support using the appropriate straps, harness system, and limb lengths based on prior measurements. Weight support was initiated at 80-100% with treadmill speed initiated at 1.5 mph (0.42 m/second) to 1.8 mph (0.5 m/second) km/hour and adjusted to the predetermined optimal treadmill speed (3.2 mph as a target) measured during the acclimation training session. Treadmill speed was modified, as tolerated, to provide an additional aerobic challenge during the peak assessment. J.W. viewed his effort via the real-time visual feedback of lower extremity force on a screen display. A Polar ® monitor recorded continuous heart rate. J.W.'s initial nine Lokomat sessions were significant only for some minor knee pain, which resolved spontaneously, and discomfort from the harness, which was resolved with repositioning. On the 10th session, preexercise BP was 104/52. Twenty minutes into the session, JW complained of exertional fatigue. The Lokomat was stopped. BP at that time was 220/ 80 mmHg and rose to 260/110 mm/Hg on a repeat measure with no symptoms other than exertional fatigue. Upon removal from the BWSTT device, his BP quickly fell to 98/50 mmHg. No skin changes were noted as possible friction points. The Lokomat straps were not obstructing urine flow from his external collecting system. No other alternate cause for the BP change could be found. The subsequent three sessions followed a similar course with regard to BP and the lack of any AD clinical symptoms; exertional fatigue only occurred during 10th session (Table 1) . A pre-exercise post-void residual obtained before the 12th session was unremarkable. Seated BPs in the harness before and after suspension were normal prior to robotic activation and without volitional movement. BP rose sharply only after commencing the 10th robotic-assisted BWSTT exercise session. The participant's BP returned to normal immediately following the termination of each session. J.W.'s participation in the research study was terminated due to concern about these repeated episodes of symptomatic elevation in BP during robotic-assisted BWSTT.
Discussion
This individual with long-standing motor incomplete tetraplegia experienced atypical AD during the active component of robotic-assisted BWSTT training using the Lokomat device. This finding was replicated across four different sessions on four different days. He experienced no recent similar episodes but has a past history of ADassociated headache during voiding. This was associated with renal stone disease with 1-2 episodes of symptomatic dysreflexia in 23 years, and none in the past 10 years. He described headache and flushing as symptoms of his prior symptomatic dysreflexia. Being strapped into the BWSTT harness with body weight unloaded did not appear to be directly causal to the elevation of BP, because it was only during the aerobic exercise facilitated by the robot exoskeleton that the BP sharply increased. In addition, J.W.'s vital signs taken during screening in the standing frame did not display signs of dysreflexia during the 30-minute time span ( Table 2 ). The clinical decision was made to stop further robotic-assisted BWSTT because of this asymptomatic AD and the concern that this activity might be harmful. Prior to BWSTT, this individual tolerated rather strenuous aerobic exercise in an upright position in an aquatic environment without observed adverse BP changes. However, midpoint BP readings were only completed through the first eight aquatic sessions with no abnormal BPs obtained. Additionally, during aggressive arm cycle ergometry BP was assessed at several midpoints with no abnormal elevation. The combination of the harness system and the aerobic stimulus (rate perceived exertion 10/10) in this individual seemed to be a crucial AD precipitating factor. With harness suspension and aerobic exercise, the modulation of vascular and sensory feedback may be diminished secondary to the SCI. 12, 14 A larger clinical matter, is the health cost-benefit analysis of exercise on cardiovascular health and the potential AD which may occur during robotic-assisted BWSTT for individuals with level of SCI at or above T6.
11,13,14-16
The presence of atypical AD in this case report provides evidence that one individual with incomplete SCI experienced sharply increased BP during robotic-assisted BWSTT activities with exertional fatigue reported in only the 10th session manifesting as the only AD clinical symptom. Identification of AD may be confounded as symptoms such as perspiration and flushing occur with aerobic exercise. Both aerobic exercise exertion and AD may be new occurrences; therefore, it may be difficult for the individual with SCI as well as the practitioner to identify the precise cause. More research is indicated to investigate how SCI affects cardiovascular function across the lifespan. The stimuli of these BP fluctuations are unknown, but silent AD may have serious, even fatal consequences, and should thereby be monitored and avoided as part of best practice. 16 
Conclusion/clinical relevance
This experience with robotic-assisted BWSTT provides data indicating the development of AD during Lokomat training for one individual with motor incomplete tetraplegia or paraplegia above the T6 level. Increased awareness of AD occurring during BWSTT for individuals with motor incomplete SCI is recommended for all clinicians conducting robotic-assisted BWSTT interventions. Frequent vital sign assessment before, during, and at the conclusion of each BWSTT training session is recommended to prevent possible complications from silent AD.
With the advent of increased access to aquatic exercise and BWSTT, it is equally important to assess midpoint BP on all individuals with SCI exercising at moderate to high intensity. Currently, we use a wrist cuff to provide easier midpoint BP and heart rate data during both aquatic and Lokomat sessions. These devices require a short interruption of exercise for 30 seconds. Investigation is ongoing of a system capable of providing BP data during Lokomat sessions. 
Introduction
Individuals with spinal cord injury (SCI) experience decreased lean muscle mass and increased total body and abdominal fat, predisposing them to a higher incidence of diabetes, hypertension, and dyslipidemia than able-bodied people (1) (2) (3) (4) . These problems, in part, are caused by neuromuscular limitations following injury and the subsequent associated sedentary lifestyle. Physical activity is recommended to combat these health related problems. Unfortunately, the person with SCI holds limited activity options. Several evidence-based guidelines exist for the able-bodied population, including the Adult Treatment Panel III, which recommends aerobic exercise to achieve cholesterol modification and weight reduction (5, 6) . However, specific available exercise guidelines are limited for individuals with SCI; and the associated restricted muscle activation, secondary metabolic derangements, and barriers to accessing exercise opportunities may limit activity engagement (7) (8) (9) .
This lack of optimal aerobic exercise recommendation for individuals with SCI partially stems from limited information about exercise peak VO 2 responses, a primary dependent variable for determining adequate aerobic training. These cardiovascular measures are difficult to reliably assess on the 'goldstandard' treadmill because muscle weakness, gait disturbances and/or use of assistive devices all may interfere with peak V0 2 assessment. Measurement of peak VO 2 assessed via arm cycle ergometry for individuals with CMISCI is currently utilized (10) (11) (12) , but the relationship between upper and lower extremity exercise is not previously reported.
Various robotic treadmill training devices provided lower extremity movement assistance for individuals with gait deficits. One device, the Lokomat®, an exoskeletal robotically assisted, body weight supported treadmill training (RABWSTT) device (Hocoma AG, Zurich, Switzerland), is included in treatment and exercise programs for individuals with MISCI. (13) The impact of Lokomat training upon the cardiovascular system of individuals with MISCI is limited (14) with little information available addressing if peak VO 2 response can be effectively and reliably obtained during robotic assisted exercise. The relationship between peak VO2 measurements during robotic treadmill 3 training and arm cycle ergometry is unknown. This information would be useful to better understand the impact of exercise interventions upon the cardiovascular fitness of individuals with MISCI.
This paper reports the test-retest reliability of both RABWSTT and arm cycle ergometer devices while eliciting peak VO 2 response in individuals with chronic motor incomplete spinal cord injury (CMISCI). Additionally, for the same population, we assess the relationship between arm cycle ergometry as the accepted tool and RABWSTT to facilitate peak VO 2 .
Materials and Methods
Participants
Twenty-one individuals with chronic (> one year post injury) motor incomplete spinal cord injury (19 males and 2 females) with ASIA Impairment Scale (AIS) C (2) or D (19) between the ages of 25-72
(average = 51.1 ± 13.7 years) agreed to participate in a three month training, randomized controlled trial to determine the RABWSTT effectiveness on gait function and aerobic capacity (Table 1) .
Participants were a convenience sample recruited from the outpatient SCI clinics at an academically affiliated 132 bed rehabilitation hospital center and an academically affiliated outpatient Department of Veterans Affairs SCI support team clinic within the same city. Eligible participants sustained a spinal cord injury at least 12 months prior to enrollment, were between 18 and 80 years old, with a confirmed level of injury between C4 and L2, and AIS of either C or D. Study participants were required to tolerate 30 vertical minutes in a standing frame, but community ambulation was not a requirement. Individuals were excluded with a history of uncontrolled hypertension, unstable angina, congestive heart failure, chronic obstructive pulmonary disease, symptomatic peripheral arterial occlusive disease or recent (within the last 3 months) hospitalization for any medical problem.
Individuals with severe contractures or frequent uncontrolled bouts of autonomic dysreflexia were also ineligible.
Methods
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Baseline evaluations included a full history and physical examination, electrocardiogram, and serum laboratory tests to screen for renal disease, liver disease and uncontrolled diabetes. Neurologic assessments were completed using the International Standards for Neurological Classification of Spinal Cord Injury. As part of the baseline testing for randomized trial, all participants also underwent Dual Energy X-ray Absorptiometry testing as well.
Lokomat Testing
All participants completed two to three 20 minute acclimation training sessions in the Lokomat prior to the measurement of peak aerobic capacity in the device with sessions designed to expose participants to the body weight support (BWS) system (0-100%) and treadmill speed (1.6-3.2 kph).
Participants performed a three minute warm-up phase in the Lokomat at the start of the peak VO 2 test with the initial work rate settings at 1.5 to 1.8 kilometers per hour (kph) for treadmill speed with robotic BWS maintained at 100%. Next, the exercise phase was initiated to induce a peak VO 2 response by periodically modifying work rates (speed and BWS) every 2-3 minutes, and treadmill speed was increased by 0.2 to 0.3 kph during these adjustment intervals. Using visual gait assessment the physical therapist reduced BWS during these adjustment intervals ideally minimizing BWS while maintaining the desired gait pattern. Participants were instructed to actively assist the robot through the gait-cycle to generate a cardiac "workout", and the RABWSTT LCD screen provided visual feedback of participant effort. Termination of each test (9-15 minutes) occurred with volitional fatigue or if the participant was unable to perform the required work rate with an appropriately aligned gait pattern.
Arm Cycle Ergometry Testing
An exercise physiologist administered all arm cycle and RABWSTT protocols including a graded exercise paradigm with periodic work rate increases until volitional fatigue occurs.
5
Participants performed two peak VO 2 arm cycle ergometer tests using a standard desktop mounted device ( Figure 1b ) with a 3-5 minute warm-up at zero resistance using a self-selected pedal cadence.
The exercise phase followed this warm-up period with the work rate adjusted every minute by increasing the resistance to the flywheel, and instruction given to maintain a self-selected rotational cadence at each new work rate. Termination of each peak test occurred at volitional fatigue or if participants could not maintain the self-selected pedal cadence. If needed, hand stability positioning straps were utilized during arm cycle ergometry.
Determination of Peak VO2 values
For both the Lokomat and arm cycle ergometer tests, air flow and gas exchange data was continuously 
Statistical Analyses
Determination of the test-retest reliability of both the arm cycle ergometer and RABWSTT to induce peak V0 2 ; and the RABWSTT V0 2 and arm cycle ergometer V0 2 relationship occurred. Individual person data was normalized to body weight in kilograms for each subject. A correlation coefficient indicated the reliability of the repeated measures for the VO2 measurements on each device separately. High reliability was defined as an r value greater than 0.85 (15) . We also assessed the two VO2 peak data from the two devices (Lokomat and arm ergometer) to examine any existing relationship.
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Statement of Ethics
The University of Maryland Baltimore Institutional Review Board, the Baltimore VA Medical Center (VAMC) Research Committee, and the Kernan Hospital Medical Executive Committee approved this protocol. We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research.
Results
Twenty one participants tolerated two sessions each of RABWSTT and arm cycle ergometry testing.
There were 15 individuals with tetraplegia based on total ISNCSCI assessment with nine of them at C4 or above and six at C5 to C8. Six individuals displayed paraplegia, five from T1 to T12 and one at 
Discussion
We are among the first research groups to investigate the test-retest reliability of peak oxygen consumption measurement using the RABWSTT and arm cycle ergometry, and evaluate the relationship between RABWSTT and arm cycle ergometry peak VO 2 (12) with mean VO 2 peak 18.6 ± 8.4
mL/kg/min, similar to our results. Hol et al concentrated on a measure of VO 2 at sub-maximal effort based on a desire to maintain constant power output during the six minutes. This was not our emphasis however, we aimed to correlate the peak measurement, which is considered the criterion standard of cardiovascular fitness during treadmill exercise testing. Sub-maximal steady state exercise would be difficult to standardize using RABWSTT given the anticipated injury variability encountered in this population.
Upright RABWSTT testing
Researchers examining the cardiovascular (CV) fitness parameters including VO 2 peak of individuals post stroke report strong test-retest reliability utilizing treadmill exercise assessments. indicating an improvement in V02 peak. (19) Consistent with our test-retest findings, this research group also reported a high reliability (r=0.95), for peak V0 2 measured during RABWSTT in a study consisting of nine men with CMISCI. (20) They concluded that robotically assisted training could be an adequate stressor of the cardiovascular system when compared in a similar way to arm crank ergometry.
Our work supports the Lokomat, a RABWSTT robotic device, besides being an exercise training choice, can be employed as a reliable and valid tool to facilitate an appropriate aerobic work challenge when assessing peak oxygen consumption for individuals with CMISCI. Our work provides further evidence of an existing relationship between VO 2 peak with upper extremity exercise and using robotically assisted leg exercise in persons with CMISCI. As we focus upon improving cardiovascular health for individuals with MISCI, this information could ultimately help optimize exercise prescription and provide positive health benefits with exercise as a component of a regular health maintenance routine. 
